Health Condition 1: null- cardio vascular problems
Conditions
Interventions
Intervention1: VASOCLEAR SYRUP: VASOCLEAR SYRUP contains Extracts made from Arjuna, Garlic, Ginger, Grape seed, Citrus, Rauvolfina serpentine etc. etc. which are natural products used for centuries in
Sponsors
RATHNA BIOTECK PvtLtd
Eligibility
Inclusion criteria
Inclusion criteria: Subject of either sex aged between 18 â?? 65 years Male and female outpatients between 18-75 Years of age. Patients having i. LDL cholesterol >130mg/dl , Serum triglycerides > or equal to 150mg/dl and Serum creatinine of Willingness and able to give informed consent and comply with requirements for participation in the study.
Exclusion criteria
Exclusion criteria: Subject who is pregnant or Lactating Any of the following is regarded as a criterion for exclusion from the study: History of serious adverse effect or hypersensitivity reactions to the medication used in the treatment of subjects in any arm of the study. Pregnant women and breast feeding History of malignancy Active liver disease or hepatic dysfunction as defined by elevations of AST or ALT greater than1.5times ULN. Uncontrolled serum CK greater than3 times ULN Serum creatinine greater than 2.5mg/dl Participation in another investigational drug trial within the previous 4 weeks diabetic foot ulcers in the last 30 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effects of Lipid Modification (LDL cholesterol lowering and HDL cholesterol raising) with VASOCLEAR syrup (3 to 4 TSP each) each time in the empty stomach and half an hour before going to bed. To evaluate the Blood Pressure Lowering with VASOCLEAR syrup (3 to 4 TSP each) each time in the empty stomach and half an hour before going to bedTimepoint: To evaluate the effects of Lipid Modification (LDL cholesterol lowering and HDL cholesterol raising) with VASOCLEAR syrup (3 to 4 TSP each) each time in the empty stomach and half an hour before going to bed. To evaluate the Blood Pressure Lowering with VASOCLEAR syrup (3 to 4 TSP each) each time in the empty stomach and half an hour before going to bed | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effects of Deep vein thrombosis (DVT) (Blood clotting disorders) Thickening, shrinking and hardening and Arteries Tolerability will be assessed based on the adverse effects as evaluated by the investigatorTimepoint: Base line and Week 6 | — |
Countries
India
Contacts
Public ContactBG Reddy
RATHNA BIOTECK Pvt.Ltd
Outcome results
None listed